OxTalks is Changing
Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Assessing Representativeness and Bias in Large Prospective Biobanks: Insights from Our Future Health
Bio: Melinda Mills is a Professor of Demography and Population Health, Director of the Leverhulme Centre for Demographic Science and Demographic Science Unit at NDPH and Nuffield College. Her work focuses on demographic change, combining multiple types of high-dimensional data and advanced statistical methods. In addition to others, she has held both an ERC Consolidator and ERC Advanced Grant, examining the intersection of social and genetic factors. She has served on No 10’s Data Science Advisory Group, as an advisor on SAGE (SPI-B), and as one of three special Advisors to the European Commissioner of the Economy. She is also a Trustee of the UK Biobank and on the Scientific Advisory Boards of Our Future Health, LifeLines, Health & Retirement Survey. She received an MBE in 2018 for her research contributions and an Honorary Doctorate in 2025 from the EUI for her work in sociogenomics. She also holds a part-time position at the Department of Economic, Econometrics & Finance, University of Groningen and Department of Genetics, University Medical Centre Groningen, Netherlands.
Abstract: The scale and coverage of biobanks offer unique opportunities to advance multiple research domains. This talk focuses on Our Future Health (OFH), which is a new prospective study aiming to recruit 5 million UK-resident adults. It examines the latest December 2025 data release where baseline phenotypic data are available for >1.9 million participants. It assesses representativeness across multiple domains of OFH against national estimates and other cohorts, particularly the UK Biobank (UKB). Phenotypes that are assessed include: self-reported health-related behaviours, geolocation, disease diagnoses and medication, in- and outpatient visits, cancer registry and cause of death. Comparisons are made across sociodemographic, lifestyle and health-related characteristics and case prevalence concordance and known clinical correlates are compared across OFH and UKB. Medication-use patterns and cancer prevalence are also examined across age-related gradients. The talk concludes with a reflection on the consequences of participation bias for different research questions and types of weighting.
Join the meeting online: teams.microsoft.com/l/meetup-join/19%3ameeting_YTlmOWQyODgtYzJhMS00NDQyLWExYmQtOTkzNmFiZWRmMWEy%40thread.v2/0?context=%7b%22Tid%22%3a%22cc95de1b-97f5-4f93-b4ba-fe68b852cf91%22%2c%22Oid%22%3a%22902ce32a-9317-4399-9f23-a83c7907d4bd%22%7d
Date:
3 March 2026, 13:00
Venue:
Richard Doll Building, Old Road Campus OX3 7LF
Venue Details:
Lecture Theatre
Speaker:
Prof. Melinda Mills (University of Oxford)
Organising department:
Nuffield Department of Population Health
Organisers:
Joanna Blaszczyk (NDPH, University of Oxford),
Sam Morris (NDPH, University of Oxford),
Michael Turner (NDPH, University of Oxford),
Dr Michelle Goonasekera (University of Oxford)
Organiser contact email address:
Michelle.Goonasekera@ndph.ox.ac.uk
Part of:
Richard Doll Seminars
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Joanna Blaszczyk
